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Harnessing and controlling self-assembly is an important step in developing proteins 
as novel biomaterials.  With this goal, here we report the design of a general 
genetically programmed system that covalently concatenates multiple distinct 
protein domains into specific assembled arrays.  It is driven by iterative intein-
mediated Native Chemical Ligation (NCL) under mild native conditions.  The system 
uses a series of initially inert recombinant protein fusions that sandwich the protein 
modules to be ligated between one of a number of different affinity tags and an 
intein protein domain.  Orthogonal activation at opposite termini of compatible 
protein fusions, via protease and intein cleavage, coupled with sequential mixing 
directs an irreversible and traceless stepwise assembly process.  This gives total 
control over the composition and arrangement of component proteins within the 
final product, enabled the limits of the system - reaction efficiency and yield - to be 
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Self-assembly systems are powerful tools found throughout Nature for building 
highly ordered and functional structures from simple starting materials (some 
examples include collagen, tubulin, laminin, and actin).  As such, manipulation and 
mimicry of these systems is an excellent step in the development of novel man-
made functional and responsive biomaterials for biotechnological applications 
1-6
.  
Proteins are arguably one of the best building blocks for such designed self-assembly 
systems.  This stems from their diverse structures and functions, coupled with their 
ability to be functionalised and easily produced by recombinant methods 
7-8
.  
However, controlling the assembly of protein units on cue into ordered 1-D, 2-D and 
3-D structures with specific directionality and precise control of spatial integration is 
an extremely difficult task.  Successful controlled assembly systems in Nature and 
design thus far have tended to use both non-covalent and covalent mechanisms that 
exhibit the following characteristics: (i) a driving force to encourage specific 
interactions between proteins, such as protein-protein interfacing or orthogonal 
covalent ligation, (ii) a mechanism to order the assembly, for example symmetry or 
repetitive docking and (iii) ideally a control mechanism to initiate or terminate the 
assembly reaction. 
 
Although there is a limited number of synthetic bioconjugation chemistries that can 
be used to control protein and peptide assembly, their scale-up costs, labelling 
limitations and orthogonality minimise their effectiveness in assembling larger 
protein arrays 
9
.  Genetically programmed assembly can circumvent a number of 
these challenges by recombinant expression of protein modules.  Successful 
engineering of such systems, and smaller peptides via solid-state synthesis, has 
mainly focused on assembly through one of the following: compatible orthogonal 
non-covalent interfaces such as dimer-trimer protein fusions, the use of orthogonal 
tags (e.g. coiled coils), protein-ligand binding or via computational interface design 
3, 
5, 10-13
.  The most commonly used means of genetically encoded covalent control has 




Truly irreversible genetically programmed covalent bonding would widen the 
potential application as well as the molecular size of assemblies that can be 
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accessed.  As, for example, these approaches provide a route to linking proteins into 
single polypeptide chains that circumvents both protein misfolding/protein synthesis 
errors associated with recombinantly producing extremely large polypeptides 
18-19
 
and technically challenging construction/recombinant production of repetitive 
and/or cytotoxic sequences 
20-21
.  Thus they enable the construction of protein 
assemblies with structures and functions as diverse as linking of multiple enzymes 
into nano-reactors 
22
, site specific modification of antibodies 
23





At present irreversible genetically programmed covalent bonding has been limited to 
a few specific enzymatically controlled cross-linking reactions 
16, 27-34
.  The most 
relevant for producing larger arrays have used: intein-mediated native chemical 
ligation (NCL) which produces a peptide bond between N- and C-termini of proteins 
27-28
 and de-constructed adhesion domains from various bacteria which “self-
catalyse” isopeptide bond formation between an aspartic acid and lysine side chains 
16, 30, 32
.  Although a designed sequential isopeptide bond-forming system has 
successfully produced large linked protein assemblies and has found exciting 
multiple uses 
16, 24-26, 30, 32
, the method does leave behind a whole protein domain at 
the site of each ligation.  In contrast, we recently designed an intein fusion protein 
system that polymerises protein modules tracelessly into single protein chains 
without leaving any unwanted polypeptide behind (Figure 1) 
19
.  Our one-pot 
synthesis system genetically encodes triggerable directional assembly via orthogonal 
chemistries at the termini of the module to be polymerised [an N-terminal cysteine 
revealed by protease cleavage and a C-terminal thioester produced from the 
excision of a Mxe GyrA intein (Mycobacterium xenopi DNA gyrase A) (Figure 1A)]. 
Here the Mxe GyrA intein acts both as a “protecting group” (inert until catalysed to 
self-excise with added reducing agent) as well as one half of the activating chemistry. 
This is in contrast to “natural intein ligation” where the intein is usually found in the 
middle of a gene and then post-translationally self-excises itself whilst ligating the 
flanking polypeptides regions together.  Although our one-pot synthesis was 
successful in producing single protein chains that extended up to microns in length, 
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it was not possible to position specific units at a predefined position or produce 
assemblies of defined lengths. 
 
Here we present a recombinant protein system that uses intein-mediated NCL to 
assemble natively folded proteins in mild native conditions in a traceless irreversible 
stepwise process with precise control. The system is driven via Mxe GyrA intein and 
is conceptually similar to stepwise peptide synthesis. It requires a minimum of two 
different fusion proteins that possess the protein units to be assembled inserted 
between differing flanking affinity protein tags. The affinity tags allow the masking of 
the reactive groups, chemical attachment of the reactants and/or products to a solid 
support (either a SPR chip or agarose beads) and easy separation of the product 
from unreacted starting components. Used in a stepwise process, the fusions gave 
total control of the composition and arrangement of component proteins within the 




System Design: Our two-component system is based on recombinantly expressing 
the protein modules to be assembled in fusion constructs termed “anchor” and 
“linkers” (Figure 2).  At the N-terminus each fusion construct contains an affinity tag 
that protects one half of the orthogonal NCL chemistry (a reactive cysteine residue) 
and enables easy purification (the anchor contains a GST tag whilst linkers contain a 
polyhistidine tag). At the C-terminus the two fusions differ more fundamentally.  The 
linkers contains a C-terminal Mxe GyrA intein to produce the complimentary half of 
the orthogonal NCL chemistry (a thioester) and a chitin binding domain affinity tag 
(CBD) for purification.  The Mxe Gyr A Intein was chosen as it has high expression 
levels in bacteria and can be purified in denaturing conditions and then easily 
refolded back into its native state. It also tolerates the presence of low levels of 
detergents and denaturants during thiol-induced cleavage. In comparison, the 
anchor contains no reactive C-terminal domains and instead contains a C-terminal 
StrepTactin tag for resin attachment if solid state synthesis is required.  Cloning, 
Page 5 of 26






























































expressing and purifying different proteins in these constructs produces natively 
folded and initially inert fusions.  Selective activation at opposing termini coupled 
with irreversible stepwise assembly, driven by NCL, enables directional construction 
of poly-proteins with specific compositions and spatial arrangements.  The 
fabrication process begins with the anchor fusion and proceeds from its N-terminus 
allowing the build-up of the protein nanostructures as follows: 
 
Fabrication via Iterative Stepwise Additions 
Activation: The anchor fusion is N-terminally activated through protease cleavage of 
its affinity tag.  The deprotection produces an N-terminal reactive cysteine (Figure 2 
& 4A).  Separately, the linker fusion is C-terminally activated via intein self-cleavage 
induced by addition of the reducing agent MESNA.  This produces a reaction-ready C-
terminal thioester (Figure 2).  
Stepwise Addition: The orthogonal C-terminal thioester activated linker is incubated 
with N-terminal cysteine activated anchor resulting in a spontaneous irreversible 
NCL reaction (Figure 2).  The reaction creates a “dimeric” protein with a traceless 
new peptide bond between the anchor at the C-terminus and the linker at the N-
terminus.  The ligated “dimeric” product has an affinity tag combination distinct 
from either of the two reactants, allowing it to be easily isolated.  
Further Stepwise Additions: During the previous ligation the linker’s N-terminal 
cysteine remains protected via its affinity tag (Figure 2).  This protected cysteine can 
be liberated as previously via protease cleavage making it reaction-ready.  A ligation 
step can then be repeated by mixing with a new C-terminally activated linker fusion 
(containing whichever protein is required).  Again the product contains a distinct 
affinity tag combination for easy purification and can be activated at its N-terminal 
for further iterative additions to occur.  Thus, through a series of sequential 
deprotection and NCL reactions the system can iteratively construct a novel protein 
nanostructure.  Moreover, as the assembly can be isolated at each step it will consist 
of a single species of exact size and composition.  
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Protein Ligation Optimisation 
High ligation yields are required due to sequential iterative nature of the assembly 
process.  To determine the optimum native conditions for reaction yield, and thus 
the limits of the system, we chose to ligate our model proteins of choice:  CTPRs 
(Consensus Tetratricopeptide repeat proteins). Initially identical CTPR3ΔS modules 
were cloned into the anchor and linker constructs.  The CTPR3ΔS modules contained 
3 consensus repeats that lacked a binding interface (termed a “spacer”).  The spacer 
CTPR3ΔS protein has been shown to be highly thermodynamically stable and highly 
resistant to aggregation 
28, 35
.  Both the anchor and linker were expressed in high 
yields with the spacer CTPRs (10-20 mgs per litre), were easily purified to > 95 % and 
activated with yields of > 90 % (SI Figure 1, Materials and Methods).  Ligation 
optimisation was carried out by varying the following parameters: using different 
proteases to activate the N-terminal cysteine, changing the protein concentrations 
and ratios, pH, salt, temperature, thiol catalysts, ligation time and time between 
activation and initiating ligation.  The results (Figure 3) show that the most important 
elements to high yielding ligations are:  
 
(i) Rapid, specific production and use of the N-terminal cysteine – Specific activation 
coupled with the time and conditions between protease cleavage and ligation of the 
cysteine were critical.  Non-specific protease cleavage or disulphide formation 
reduced the available react-able cysteines and the longer the correctly 
cleaved/activated cysteine was left at room temperature before ligation, the lower 
the reaction yield (Figure 3A).  Thus the highest yielding ligations were achieved 
when protein was activated quickly in a highly reduced environment and stored at -
80 °C. Of the protease’s trialled (TEV, Thrombin and Factor Xa), both Thrombin and 
Factor Xa slowed significantly in the presence of reducing agent and, in the case of 
Factor Xa, produced a significant percentage of promiscuous cleavage (SI Figure 2).  
Only TEV gave the specific and fast cleavage in the reducing environment required 
(SI Figure 3).  Therefore, all our fusion designs only possess TEV cleavage sites and 
were performed with TCEP to keep a highly reduced environment. 
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(ii) Optimum temperature, protein concentration & pH – After the importance of 
the N-terminal cysteine, temperature, pH and protein concentration were found to 
be the most important factors.  The optimum reaction temperature and pH were 
found to be 30 °C and pH 8.5, higher temperature/pH decreased yield through non-
specific aggregation and degradation (Figure 3C & D).  In a similar manner, synthetic 
peptide to peptide NCL studies have shown that high reaction yields are achieved 
the use of a high concentration and large molar excesses of attacking peptide 
reactant (usually > 1 mM and in a 10:1 ratio 
21
).  This is generally carried out in the 
presence of strong denaturants to prevent aggregation [for example, 6 M Guanidine 
Hydrochloride (GuHCl)].  Clearly such harsh conditions are undesirable for protein 
self-assembly; as this would cause protein denaturation and thus require added 
refolding complications.  The high stability and resistance to aggregation (can be 
concentrated to the low mM range) of the CTPR3ΔS spacer module enabled the NCL 
reaction to be trialled over a range of protein concentrations and molar ratios under 
native conditions (Figure 3G, SI Fig 4).  At higher concentrations the yields were 
significantly higher, and increasing the molar ratio of thioester to cysteine reactant 
similarly improves percentage yield.  However, such high concentrations can only be 
achieved with the most “amenable” protein domains.  Therefore protein 
concentrations in the μM range were chosen (100 μM spacer to 50 μM anchor) in a 
2:1 ratio (thioester to cysteine).  
 
(iii) Identity and buffer conditions of the C-terminal thioester – In contrast to the N-
terminal cysteine, the MESNA produced C-terminal thioester remains highly active 
for at least 3 days, with significant loss of reactivity only after 7 days (when in an 
excess of MESNA) (Figure 3B).  Peptide studies have shown the identity of the 
thioester can affect reaction rates, therefore the MESNA formed thioesters were 
exchanged through incubation with the known activator 4-carboxymethyl thiophenol 
(MPAA) and deactivator dithiothreitol (DTT) 
36
.  In line with these studies, ligation 
rates and initial yields increased with MPAA or were greatly reduced with DTT 
(Figure 3).  However, increasing the time of ligation to 24 hours and using a higher 
concentration of MESNA produced similar yields to the 16 hour MPAA incubated 
reactions.  Thus ligations were performed with less expensive MESNA formed 
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thioester for 24 hours in buffers containing > 100 mM MESNA and where all DTT was 
replaced with TCEP.  Finally, most of the solubilising additives trialled had little 
effect, except for NaCl and glycerol which increased and decreased the reaction yield 
slightly, respectively (Figure 3H).  
 
Sequential Ligations and nanostructure formation 
From the optimisation studies above, final ligation conditions of 100 μM activated 
thioester linker to 50 μM activated cysteine anchor in 50 mM Tris-HCl, 500 mM NaCl, 
200 mM MESNA, 10 mM TCEP, pH 8.5, 30 ˚C for 24 hours were used.  An average 
final reaction yield of approximately 75 % ± 5.5 was achieved (SI Figure 4).  This 
suggests that the highest feasible number of sequential ligations that could be 
performed would be 6 and produce a final yield of ≈ 18 %.  However, although the 
yield for each NCL is high, it is still within the range that necessitates purifying the 
product from the reactants after each reaction step (avoiding cross reactivity in 
future ligation steps).  The additional purification requirement results in good overall 
recovery of ligation product (75 to 50 %).  A higher recovery was always obtained 
when new StrepTactin® resin (resin-bound tetrameric streptavidin) was used, with 
greater losses as the resin aged.  Therefore, combined yield after each stepwise 
addition is ~50 %, suggesting that 3 to 4 sequential ligations joining 4 to 5 protein 
modules together is the realistic limit of the system.  
To show such feasibility we therefore undertook a series of ligation reactions using 
the spacer CTPR3ΔS. Figure 4B shows a typical three sequential ligation sequence 
(the reactants and products of each ligation were verified by Mass Spectrometry – SI 
Figure 1 & 5).  The yield for each individual NCL addition was consistent with 
previously obtained yields and after each ligation the product was successfully 
purified to > 90 % and re-activated to > 95 %.  The final product, a semi-synthetic 
CTPR12ΔS protein consisting of 4 CTPR3ΔS subunits, was > 90 % pure and correctly 
folded (as monitored by Far UV Circular Dichroism – SI Fig. 5).  Moreover, as a CTPR 
domain of between 18 and 20 motifs can be reliably expressed recombinantly, a 
protein fibril of at least 60 motifs or more, equating to ~50-70 nm in length, could be 
reliably produced.  
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Functionalising Ligated Nano-structures  
Given the success of the bare-bone ligations, the next step was to introduce 
functionality to the nanostructures.  This was achieved by placing new “binding” 
CTPR modules at specific spatial locations within the fabricated CTPR ensemble.  The 
new module consisted of a CTPR6ΔS monomer constructed from a “spacer” CTPR3ΔS 
unit fused to a “binding” CTPR3ΔS unit (S.I Figure 1C).  The “binding” CTPR3ΔS 
domain chosen was designed and developed by Regan and co-workers and was 
capable of associating with the pentapeptide amino acid sequence – MEEVD 
37
.  The 
CTPR6ΔS gene was cloned into the linker fusion and was recombinantly expressed at 
yields of 5 - 10 mgL
-1
.  The expressed fusion was then activated to a thioester 
monomer and purified to > 95 % (S.I Figure 1C). To form a “functional” 
nanostructure, i.e. one with binding capability, three stepwise NCL reactions were 
performed with the spacer-containing anchor and “binder” CTPR6ΔS-containing 
linkers. Reactions were performed as previously, except the ligation temperature 
was reduced to 25 °C to prevent aggregation (the “binder” construct was more 
prone to aggregation than the “spacer” constructs at higher concentrations).  Figure 
4C shows a 3 sequential reaction fabrication with the final CTPR21ΔS protein (≈ 92 
kDa) confirmed by ESI Mass Spectrometry (SI Figure 5).  As with the previous 
stepwise ligations, the product of each ligation was separated from its reactants (70-
95 %) and reactivated to >95 %.  When the ligation yields of these reactions were 
compared with the sequential spacer additions performed at 30 °C, they were found 
to be lower.  This was expected and in line with yields of the “spacer” when ligated 
at 25 °C.  The newly synthesized CTPR21ΔS protein produced is directly comparable 
to the CTPR18 protein that Regan and co-workers used to form smart hydrogels 
through mixing with a 4-armed PEG-peptide linker 
4
.  Thus, by ligating specific 
modules (in this case binding and spacer CTPRΔS domains) at predetermined spatial 
locations, our system can produce a semi-synthetic functional nanostructure. 
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Herein we have developed a general recombinant protein system that utilises 
genetically programmed intein-mediated NCL to irreversibly and sequentially 
assemble large user-defined protein architectures from smaller protein domain 
building blocks.  Under mild conditions natively folded protein domains react to 
produce a traceless peptide-bond linked product (with a purity of > 90 %) with no 
intervening tag and no requirement for chemical modification. Thus no 
bioconjugations or refolding steps are required. Furthermore, at the relatively low 
protein concentrations used (100 µM C-terminal thioester to 50 µM N-terminal 
cysteine reactants), the system should to be widely accessible to numerous protein 
systems. With such reaction conditions each sequential ligation step was optimised 
to yield 75 % product, generating a realistic limit of the system of 3 to 4 sequential 
ligations joining 4 to 5 protein modules together. Proteins that are soluble up to 
higher concentrations would increase this yield even further and enable an 
expansion to a greater number of sequential steps. Moreover, as the anchor 
construct possesses a C-terminal StrepTactin tag the system could be attached to 
resin if solid state synthesis via, for example, Biacore™ is required. 
 
Using the assembly system we have shown that modules made from 3 or 6 
consensus TPR motifs can be natively assembled into functional proteins of up to 21 
CTPR motifs (≈ 92 kDa). In particular, this strategy allowed us to place binding 
modules at specified locations to enable gelation with a four-armed PEG-peptide 
linker. Thus, our system provides: (i) a novel semi-synthetic shortcut to the 
production of giant repetitive proteins that are challenging to produce via molecular 
biology and (ii) has the potential to create customised protein-based biomaterials 
comprising multiple functionalisable protein elements that can be specifically 
orientated within the final protein architecture. One future avenue would be to 
create two- and three-dimensional lattices or cages through addition of oligomeric 
domains into the anchor and linker constructs. Other uses could include the semi-
synthesis of cytotoxic proteins from multiple non-toxic protein units or for the 
synthesis of protein multimers that are too large to be produced recombinantly as 
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single polypeptide chain (≈ 100 kDa E.coli). Furthermore, this semi-synthetic 
approach would enable additional modifications to be incorporated that are difficult 
to achieve via recombinant techniques. Such modifications could include the 
insertion of a monomer unit containing a non-natural amino acids (for example, 
azido-amino-acids used in Click chemistry) which could enable attachment of other 
components to the protein scaffold. 
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Construction of Fusion Protein Genes & Vectors: A detailed description of the 
construction and cloning of the fusion protein genes used are described in the 
Supplementary Information (SI). 
 
Protein Production and Purification: All fusion proteins were obtained by 
recombinant E. coli expression and purification by standard affinity chromatography 
techniques used previously 
28
 or outlined in Supplementary Information (SI).   
 
Activation for Native Chemical Ligation: To make each fusion protein reaction-
ready, they were activated at either the N- or C-termini via: (i) cysteine liberation or 
(ii) thioester formation, respectively:  
(i) N-terminal Activation: The N-terminal cysteine was liberated by removing the 
protective affinity tag by protease cleavage.  Three proteases were trialled: Tobacco 
Etch Virus (TEV), Factor Xa and Thrombin. Both TEV and Thrombin required modified 
cleavage sequences to liberate the N-terminal cysteine. The TEV protease cleavage 
was mutated to ENLYFQ↓C, from the commonly used site ENLYFQ↓G and the 
Thrombin protease sequence was mutated from LVPR↓(G/S) to LVPR↓C. Factor Xa 
cleaves directly after the 4 amino acid sequence IEGR, therefore the native cleavage 
site was utilised. 100 μM protein fusions were cleaved at 25 °C in 50 mM Tris-HCl pH 
8, 150 mM NaCl, for 16 hours (10 mM TCEP was added to the reaction mixture for 
TEV cleavage and 0.1 mM TCEP for both Thrombin and Factor Xa). Post-cleavage 
affinity chromatography, using either Ni-NTA or GST resin depending on the N-
terminal tag, facilitated the easy removal of both the cleaved affinity tag and un-
cleaved fusion protein. After purification, the activated proteins were flash frozen 
and stored at -80 °C. 
(ii) C-terminal Activation: The C-terminal thioester was formed by Sodium 2-
mercaptoethanesulfonate (MESNA) triggered cleavage of the C-terminal Mxe GyrA 
intein fusion. Proteins were either bound to chitin resin and cleaved via incubation 
at 25 °C for 16 hours with cleavage buffer (50 mM Tris-HCl pH 8, 150 mM NaCl, 10 % 
w/v MESNA) or cleaved in the cleavage buffer at 100 μM concentration and then 
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purified via chitin resin. In both cases the C-terminal thioester-containing cleaved 
protein does not bind the chitin resin and is eluted, whereas the excised intein and 
un-cleaved fusion protein remains attached to the chitin beads via its chitin binding 
domain affinity tag. The formation of the C-terminal thioester was estimated to be 
80 % or 95 % efficient depending on whether cleaved on or off the chitin resin, 
respectively. The cleaved thioesters were > 90 % pure after elution from the chitin 
resin (by SDS PAGE analysis S.I Figure 1). After purification, the activated proteins 
were flash frozen and stored at -80 °C. 
 
Protein Ligation Reactions: Protein ligations were carried out in a ligation buffer of 
50 mM Tris-HCl, 150 mM NaCl, 5 % (w/v) MESNA and 10 mM TCEP. Differing protein 
concentrations and ratios, pH, salt, temperature, thiol catalysts, ligation time and 
time between activation and initiating ligation were then investigated. The reactions 
were left to proceed under mild agitation. A small amount of urea (0.1-0.5 M) was 
added to the buffer to prevent any trace amounts of TEV protease causing any 
premature N-terminal activation of reactants.  
 
Reaction Yields: All purification steps, cleavage and ligation reactions were 
monitored and confirmed by SDS-PAGE electrophoresis and either MALDI or 
Electrospray Mass Spectrometry (SI Materials & Methods). An Odyssey LI-COR in 800 
nm imaging channel was used to quantify values for reaction yields of purification, 
cleavage and ligation reactions from the SDS-PAGE gels. Integrated intensity values 
(I) corresponding to each protein band were thereby obtained, and equation 1 was 
used to obtain the percentage of N-cysteinyl-containing protein successfully ligated 






MolecWt	L 	.		IL+IC  .100  (1) 
 
where MolecWt C is the molecular weight of N-cysteinyl reactant, MolecWt L is the 
molecular weight of NCL product, IC is the Integrated Intensity of N-cysteinyl 
reactant and IL is the Integrated Intensity of NCL product. Equation 1 assumes that 
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the binding of Coomassie stain (and, therefore, the intensity) is linearly related to 
the molecular weight of each NCL reactant protein. This is a reasonable assumption 
given that all reactants are consensus tetratricopeptide repeat containing proteins 
(CTPR).  
 
Accuracy and reproducibility of the ligation reactions: The accuracy and 
reproducibility of the ligation reactions was determined in triplicate, with 8 
experiments performed 5 times. Reproducibility of the ligation reaction between 
protein preparations was also investigated by comparing optimised reaction 
condition yields between 4 differing protein preparations. In all cases the standard 
deviation for each experiment did not exceed 6.5 % of the yields reported and 
generally produced a standard deviation of between 1 and 2.5 % (SI Figure 4E).  
When comparing ligation yields between protein preparations, the standard 
deviation produced was 3.7 % (SI Figure 4E). Thus, the experimental yield analysis is 
robust, with the variation between protein preparations within the error of the 
experiment and analysis. 
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Supplementary Materials and Methods: construction of fusion protein genes and 
vectors, expression and purification of fusion proteins, protein storage, confirmation 
of products and reaction yields, N-terminal activation of differing proteases and their 
efficiency.  
Supplementary Figures: SDS PAGE gel / mass spectrometry analyses of the 
purification and activation of various anchor and linker fusions with differing 
proteases, SDS PAGE analyses of one-pot polymerisation reactions activated with 
various proteases, SDS PAGE analyses of the repeatability of ligation experiments 
and mass spectrometry and far-UV circular diochroism of nanostructures formed 
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Figure 1: (a) Schematic of the recombinant fusion protein and activation method used 
by Main and co-workers to produce a one-pot NCL mediated polymerisation system 
28
. 
The arrows show where Factor Xa and MESNA cause the fusion protein to be cleaved 
yielding an activated and polymerisation ready CTPR3ΔS protein monomer with an N-
terminal cysteine & C-terminal thioester. [The structure of the CTPR3ΔS protein is based 
on the structure of CTPR3 (i.e. identical minus C-terminal S-helix)]. (b) Scheme for native 
chemical ligation (NCL) polymerization of activated CTPRΔS protein monomers. (1) 
Monomers (topologically drawn) can only react to at orthogonal N- and C-termini 
driving the formation a head-to-tail covalent dimer, which undergoes N-acyl 
rearrangement to yield a peptide bond. (2) These then dock to produce a continuous 
CTPR superhelix. 
 
Figure 2: (a - c) Schematic of the designed recombinant fusion proteins, their 
activation & stepwise nanostructure formation. Two fusion proteins coupled with 
selective activation and mixing are required for successful assembly. The two fusions 
were termed: (a) “anchor” and (b) “linker”. Each possess the protein units to be 
assembled (shown as protein 1 through to protein n) inserted between differing flanking 
affinity protein tags.  
(a) The anchor & its N-terminal activation: The anchor fusion possesses an N-terminal 
Glutathione-S-Transferase (GST) and a C-terminal StrepTactin (Strep) affinity tag. The 
anchor can only be activated at its N-termini via protease cleavage of the protecting GST 
tag (arrow signifies cleavage site). This liberates an active N-terminal cysteine (one half 
of the NCL chemistry). 
(b) The linkers & their C-terminal activation: The linker fusions have an N-terminal 6 X 
Histidine (His6), a Mxe GyrA intein (INTEIN) and a C-terminal chitin binding domain 
affinity tag (CBD). In contrast to the anchor, linkers can be activated at both their N- and 
C-termini. Initially, all linkers are only activated at their C-termini via addition of Sodium 
2-mercaptoethanesulfonate (MESNA - arrow signifies cleavage site). The MESNA induces 
the intein to spontaneously self-cleave, producing an active C-terminal thioester (the 
other half of the NCL chemistry). The CBD enables removal of the cleaved intein. 
(c) Schematic stepwise nanostructure formation. (NCL1) Activated anchor and linker 
are mixed and a spontaneous native chemical ligation takes place between the anchor’s 
N-terminal cysteine and the linker’s C-terminal thioester. The irreversible reaction 
produces a traceless peptide bond. The product is isolated and reactivated by protease 
cleavage.  (NCL2) The activated fusion can then be combined with, for example, an 
activated linker which has a different module to undergo another iterative round of 
ligation. These steps can be repeated (dotted arrow) through multiple rounds of NCL to 
produce nanostructures composed of differing protein modules in precise spatial arrays. 
 
Figure 3: (a - h) NCL optimsation reactions. (a & b) Reaction yield after pre-ligation 
incubation of either (a) N-terminal activated CTPR3ΔS anchor or (b) C-terminal activated 
CTPR3ΔS linker at 4 °C followed by ligation to its reaction partner. Insets: SDS-PAGE 
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analysis of ligation yield after varying pre-ligation incubation times: Lane 1, 0 hours 
ligation; Lane 2, 24 hours ligation without pre-incubation; Lanes 3-7, 24 hours ligation 
after 24, 48, 72 and 168 hours of pre-incubation. (c -f) Quantification from SDS Page gels 
of the NCL reaction yield between N-terminal activated CTPR3ΔS anchor and C-terminal 
activated CTPR3ΔS linker over a time course of 48 hours whilst varying (c) temperature, 
(d) pH, (e) concentration of MESNA, (f) concentration of MPAA and after 24 hours whilst 
varying (g) concentration and (f) on the addition of buffer additives. Errors show 1 
standard deviation. Insets in each show example SDS-PAGE gels from the time courses.  
 
Figure 4:(a) Scheme of stepwise nanostructure formation with 3 NCL steps. Activated 
anchor and linker 1 were combined and a spontaneous native chemical ligation takes 
place between the cysteine and thioester. The irreversible reaction produces a peptide 
bond.  The product is isolated and reactivated by TEV protease cleavage.  The activated 
fusion was then combined with further activated linkers to undergo iterative rounds of 
ligation until 3 NCL reactions have occurred. 
(b) SDS-PAGE analysis of 3 sequential native chemical ligations between spacer 
CTPR3ΔS modules. Lane 1, Protein Marker; Lane 2, activated anchor; Lane 3, activated 
linker; Lane 4, NCL1 0 hour; Lane 5, NCL1 24 hour; Lane 6, CTPR6ΔS product of NCL1; 
Lane 7, Activated of CTPR6ΔS product; Lane 8, NCL2 0 hour; Lane 9, NCL2 24 hour; Lane 
10, CTPR9ΔS product of NCL2; Lane 11, Activated CTPR9ΔS product; Lane 12, NCL3 0 
hour; Lane 13, NCL3 24 hour; Lane 14, CTPR12ΔS product of NCL3; Lane 15, Protein 
marker.  
(c) A) SDS-PAGE analysis of 3 sequential native chemical ligations between spacer 
CTPR3ΔS anchor and binder CTPR6ΔS linker modules. Lane 1, Protein Marker; Lane 2, 
activated spacer CTPR3ΔS anchor; Lane 3, activated binder CTPR6ΔS linker; Lane 4, NCL1 
0 hour ; Lane 5, NCL1 24 hour; Lane 6, CTPR9ΔS product of NCL1; Lane 7, activated 
CTPR9ΔS product; Lane 8, activated binder CTPR6ΔS linker; Lane 9, NCL2 0 hour; Lane 
10, NCL2 24 hour; Lane 11, CTPR15ΔS product of NCL2; Lane 12, activated CTPR15ΔS 
product; Lane 13, activated binder CTPR6ΔS linker; Lane 14, NCL3 0 hour; Lane 15, NCL3 
24 hour; Lane 16, CTPR21ΔS product of NCL3; Lane 17, Protein marker.  
Note, masses of the CTPR proteins seem smaller than expected on the SDS PAGE gels 
due to “gel shifting” (they migrate faster than proteins of similar molecular weight). 
Mass spectrometry confirmed the molecular weights of the final products (SI Figure 5). 
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Figure 1: (a) Schematic of the recombinant fusion protein and activation method used by Main and co-
workers to produce a one-pot NCL mediated polymerisation system 28. The arrows show where Factor Xa 
and MESNA cause the fusion protein to be cleaved yielding an activated and polymerisation ready CTPR3∆S 
protein monomer with an N-terminal cysteine & C-terminal thioester. [The structure of the CTPR3∆S protein 
is based on the structure of CTPR3 (i.e. identical minus C-terminal S-helix)]. (b) Scheme for native chemical 
ligation (NCL) polymerization of activated CTPR∆S protein monomers. (1) Monomers (topologically drawn) 
can only react to at orthogonal N- and C-termini driving the formation a head-to-tail covalent dimer, which 
undergoes N-acyl rearrangement to yield a peptide bond. (2) These then dock to produce a continuous CTPR 
superhelix.  
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Figure 2: (a - c) Schematic of the designed recombinant fusion proteins, their activation & stepwise 
nanostructure formation. Two fusion proteins coupled with selective activation and mixing are required for 
successful assembly. The two fusions were termed: (a) "anchor" and (b) "linker". Each possess the protein 
units to be assembled (shown as protein 1 through to protein n) inserted between differing flanking affinity 
protein tags.  
(a) The anchor & its N-terminal activation: The anchor fusion possesses an N-terminal Glutathione-S-
Transferase (GST) and a C-terminal StrepTactin (Strep) affinity tag. The anchor can only be activated at its 
N-termini via protease cleavage of the protecting GST tag (arrow signifies cleavage site). This liberates an 
active N-terminal cysteine (one half of the NCL chemistry).  
(b) The linkers & their C-terminal activation: The linker fusions have an N-terminal 6 X Histidine (His6), a 
Mxe GyrA intein (INTEIN) and a C-terminal chitin binding domain affinity tag (CBD). In contrast to the 
anchor, linkers can be activated at both their N- and C-termini. Initially, all linkers are only activated at their 
C-termini via addition of Sodium 2-mercaptoethanesulfonate (MESNA - arrow signifies cleavage site). The 
MESNA induces the intein to spontaneously self-cleave, producing an active C-terminal thioester (the other 
half of the NCL chemistry). The CBD enables removal of the cleaved intein.  
(c) Schematic stepwise nanostructure formation. (NCL1) Activated anchor and linker are mixed and a 
spontaneous native chemical ligation takes place between the anchor's N-terminal cysteine and the linker's 
C-terminal thioester. The irreversible reaction produces a traceless peptide bond. The product is isolated and 
reactivated by protease cleavage.  (NCL2) The activated fusion can then be combined with, for example, an 
activated linker which has a different module to undergo another iterative round of ligation. These steps can 
be repeated (dotted arrow) through multiple rounds of NCL to produce nanostructures composed of differing 
protein modules in precise spatial arrays.  
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Figure 3: (a - h) NCL optimsation reactions. (a & b) Reaction yield after pre-ligation incubation of either (a) 
N-terminal activated CTPR3∆S anchor or (b) C-terminal activated CTPR3∆S linker at 4 °C followed by 
ligation to its reaction partner. Insets: SDS-PAGE analysis of ligation yield after varying pre-ligation 
incubation times: Lane 1, 0 hours ligation; Lane 2, 24 hours ligation without pre-incubation; Lanes 3-7, 24 
hours ligation after 24, 48, 72 and 168 hours of pre-incubation. (c -f) Quantification from SDS Page gels of 
the NCL reaction yield between N-terminal activated CTPR3∆S anchor and C-terminal activated CTPR3∆S 
linker over a time course of 48 hours whilst varying (c) temperature, (d) pH, (e) concentration of MESNA, (f) 
concentration of MPAA and after 24 hours whilst varying (g) concentration and (f) on the addition of buffer 
additives. Errors show 1 standard deviation. Insets in each show example SDS-PAGE gels from the time 
courses.  
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Figure 4:(a) Scheme of stepwise nanostructure formation with 3 NCL steps. Activated anchor and linker 1 
were combined and a spontaneous native chemical ligation takes place between the cysteine and thioester. 
The irreversible reaction produces a peptide bond.  The product is isolated and reactivated by TEV protease 
cleavage.  The activated fusion was then combined with further activated linkers to undergo iterative rounds 
of ligation until 3 NCL reactions have occurred.  
(b) SDS-PAGE analysis of 3 sequential native chemical ligations between spacer CTPR3∆S modules. Lane 1, 
Protein Marker; Lane 2, activated anchor; Lane 3, activated linker; Lane 4, NCL1 0 hour; Lane 5, NCL1 24 
hour; Lane 6, CTPR6∆S product of NCL1; Lane 7, Activated of CTPR6∆S product; Lane 8, NCL2 0 hour; Lane 
9, NCL2 24 hour; Lane 10, CTPR9∆S product of NCL2; Lane 11, Activated CTPR9∆S product; Lane 12, NCL3 
0 hour; Lane 13, NCL3 24 hour; Lane 14, CTPR12∆S product of NCL3; Lane 15, Protein marker.  
(c) A) SDS-PAGE analysis of 3 sequential native chemical ligations between spacer CTPR3∆S anchor and 
binder CTPR6∆S linker modules. Lane 1, Protein Marker; Lane 2, activated spacer CTPR3∆S anchor; Lane 3, 
activated binder CTPR6∆S linker; Lane 4, NCL1 0 hour ; Lane 5, NCL1 24 hour; Lane 6, CTPR9∆S product of 
NCL1; Lane 7, activated CTPR9∆S product; Lane 8, activated binder CTPR6∆S linker; Lane 9, NCL2 0 hour; 
Lane 10, NCL2 24 hour; Lane 11, CTPR15∆S product of NCL2; Lane 12, activated CTPR15∆S product; Lane 
13, activated binder CTPR6∆S linker; Lane 14, NCL3 0 hour; Lane 15, NCL3 24 hour; Lane 16, CTPR21∆S 
product of NCL3; Lane 17, Protein marker.  
Note, masses of the CTPR proteins seem smaller than expected on the SDS PAGE gels due to "gel shifting" 
(they migrate faster than proteins of similar molecular weight). Mass spectrometry confirmed the molecular 
weights of the final products (SI Figure 5).  
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